Navigation Links
First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System
Date:5/15/2008

lipid core containing plaques of interest in the coronary arteries. For more information, visit the InfraReDx website at http://www.infraredx.com .

InfraReDx Company Contacts:

Media Contact:

Diane Kemp, Marketing Manager

InfraReDx, Inc.

(781) 221-0053 x. 341

dkemp@infraredx.com

Investor Contact:

Andrew Jordan, Chief Financial Officer

InfraReDx, Inc.

(781) 221-0053 x. 229

ajordan@infraredx.com

Physician Contact for Interviews:

Gregg W. Stone, MD

Mobile: 646-785-9591

Email: gstone@crf.org


'/>"/>
SOURCE InfraReDx, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
6. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
7. Tainted Chinese Food Ingredients First Discovered in 2005
8. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
11. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... 2014  As the Medical Affairs, role has become ... this area are exploring methods to develop strong capabilities ... Consortium at Best Practices, LLC is designed to give ... the key challenges they face. The consortium will provide ... virtual roundtable discussions where leaders discuss key findings from ...
(Date:8/22/2014)... Ohio , Aug. 22, 2014 MC Medical, ... Inc. (MID), a Columbus, OH medical ... distribute the FloShield laparoscopic and robotic visualization system in ... be approved for sale in Japan ... a long-time experience and an extensive product portfolio in endoscopic ...
(Date:8/22/2014)... Aug. 22, 2014  Research presented at the 29 th ... developed by Hera Therapeutics Inc. combats three types of human ... cervical cancer. When tested in several cultured human ... HPV-11 cells, according to Louise T. Chow , Ph.D. ... at the Seattle conference. The National ...
Breaking Medicine Technology:Best Practices' Medical Affairs Consortium Survey Has Achieved Strong Participation 2MC Medical agrees to be the exclusive distributor of FloShield products in Japan 2Study shows Hera Therapeutics experimental compound shuts down human papillomavirus that causes most cervical cancer 2
... KALAMAZOO, Mich., Sept. 9 Global Pharmaceutical Services ... the worldwide pharmaceutical and biotechnology industry announces a new clinical ... has entered into an exclusive partnership with Abridge Clinical Research ... India. "We are delighted in working with such an experienced ...
... , IRVINE, Calif., Sept. 8 ... U.S. Food and Drug Administration (FDA) has approved Bepreve(TM) (bepotastine besilate ... ocular itching associated with allergic conjunctivitis in patients two years of ... new, safe and effective way to treat the itching caused by ...
Cached Medicine Technology:Life Sciences Company Opens Clinical Trial Bridge to India 2ISTA Pharmaceuticals' Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies 2ISTA Pharmaceuticals' Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies 3ISTA Pharmaceuticals' Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies 4ISTA Pharmaceuticals' Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies 5
(Date:8/22/2014)... Penn Medicine team has found that targeted automated ... tract infections in hospital patients with urinary catheters. ... was simplified, the rate of improvement dramatically increased. ... patients need urinary catheters in the first place ... for catheters that have not been removed within ...
(Date:8/22/2014)... Natural Clear Vision , a how-to guide ... vision from legally blind to perfect 20/20 vision has caught ... , “There is a huge portion of the population today ... most people just think that’s the way it will always ... be pretty risky at times,” reports Michaels. “This program is ...
(Date:8/22/2014)... Epidermal growth factor receptor (EGFR) mutations found in the ... advanced non-small cell lung cancer (NSCLC) patients correlates well ... , EGFR tyrosine kinase inhibitor (TKI) therapy is approved ... but the standard for determining mutation status is with ... limited or not available. A more abundant and less ...
(Date:8/22/2014)... York, New York (PRWEB) August 22, 2014 ... continue to be filed in U.S. courts on ... events due to their use of prescription low ... court documents, a new claim was filed against ... man who allegedly suffered life-threatening heart issues due ...
(Date:8/22/2014)... FRIDAY, Aug. 22, 2014 (HealthDay News) -- An intensive effort ... to an animal shelter in Florida and euthanized, a new ... enough cats to slow their intake into animal control," Dr. ... of Florida College of Veterinary Medicine, said in a university ... there wasn,t making a big impact," she explained, "so we ...
Breaking Medicine News(10 mins):Health News:Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections 2Health News:Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections 3Health News:Natural Clear Vision: Review Exposes Kevin Richardson’s Program for Restoring Vision Naturally 2Health News:High concordance between EGFR mutations from circulating-free tumor DNA and tumor tissue in non-small cell lung cancer 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 4Health News:Neutering Project Curbed Feral Cat Population 2
... Pharmacopeia,(Nasdaq: PCOP ), an innovator in ... today announced that it has licensed from,Bristol-Myers Squibb ... modulator,(SARM) program, including a lead compound in Phase ... non-steroidal selective androgen,receptor modulator, or SARM, which was ...
... Ill. A study published in the October ... (JCSM) finds that modafinil is well-tolerated in the treatment ... wakefulness such as shift work sleep disorder, obstructive sleep ... or sleep parameters. , The study, authored by Thomas ...
... 15 With school schedules now routine and,the initial ... again",sighs. This might be a good time to re-evaluate ... http://www.newscom.com/cgi-bin/prnh/20071015/NYFNSL01 ) The following are suggestions ... and snacks for greater nutritional impact. Add a,handful of ...
... - ,Real Women, Real Pain, Campaign Highlights ... in Women Around the World Today, the International ... the Global Year Against Pain in Women to draw ... and the need for more,effective care. Lack of awareness ...
... A new study by Rhode Island Hospital and Brown University ... surgery did not receive the initial psychiatric clearance for the ... of decisions to clear candidates for surgery, and the largest ... and detail the reasons for exclusion. It was published in ...
... Attention-deficit/hyperactivity disorder (ADHD), a state of serious impairments in ... many labels for one of the most prevalent conditions ... partly persists into adulthood. ADHD is conservatively estimated to ... 1998), but more permissive criteria yield estimates of up ...
Cached Medicine News:Health News:Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb 2Health News:Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb 3Health News:Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb 4Health News:Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb 5Health News:Study: Modafinil is effective in treating excessive sleepiness 2Health News:Fresh, Tasty - Healthy - Lunch and Snack Ideas 2Health News:International Association for the Study of Pain (IASP) Declares the Global Year Against Pain in Women 2Health News:International Association for the Study of Pain (IASP) Declares the Global Year Against Pain in Women 3Health News:1 in 5 bariatric surgery candidates not psychologically cleared for surgery 2Health News:Computerized training of working memory is a promising therapeutic strategy in ADHD 2Health News:Computerized training of working memory is a promising therapeutic strategy in ADHD 3
... Instruments were developed in surgeon's desire to ... having an instrument with the strength to ... of the bending or breaking. Arthrotek Hand ... conform to the surgeon's hand. This new ...
This optimal design addresses low-cost, simple, non-invasive ankle distraction....
... BTA stat Test is an ... qualitative detection of bladder tumor ... with bladder cancer. This test ... aid in the management of ...
... TheraTears Liquid Gel is a thicker version ... or for those who need a longer-lasting ... Liquid Gel is so long-lasting, it is ... preserved gels, there never needs to be ...
Medicine Products: